A Randomized, Placebo-controlled, Double-blind Phase II Study to Evaluate the Efficacy of IZN-6D4 Gel for the Treatment of Diabetic Foot Ulcers

NCT01427569 Phase 2 COMPLETED

The purpose of this study is to determine if topical application of a hydrogel that contains plant extracts will improve healing of diabetic foot ulcers when compared to treatment with a hydrogel alone.

Details

Lead sponsor	Izun Pharma Ltd
Phase	Phase 2
Status	COMPLETED
Enrolment	82
Start date	2012-03
Completion	2015-08

Conditions

• Diabetic Foot Ulcer

Interventions

• IZN-6D4 Gel
• Placebo hydrogel

Primary outcomes

• The percent reduction in wound area at week 4 compared to the baseline visit — Weekly measurements of wound area from study initiation and through week 4

Countries

Israel